Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis With Poor Kidney Function: A Subgroup Analysis of the Aspreva Lupus Management Study-Reference-Cited by-同舟云学术

Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis With Poor Kidney Function: A Subgroup Analysis of the Aspreva Lupus Management Study

Published:2013-05 Issue:5 Volume:61 Page:710-715
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Walsh Michael,Solomons Neil,Lisk Laura,Jayne David R.W.

Publisher

Elsevier BV

Subject

Nephrology

Reference15 articles.

1. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis;Appel;J Am Soc Nephrol,2009

2. Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS);Sinclair;Lupus,2007

3. The classification of glomerulonephritis in systemic lupus erythematosus revisited;Weening;Kidney Int,2004

4. The classification of glomerulonephritis in systemic lupus erythematosus revisited;Weening;J Am Soc Nephrol,2004

5. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract];Levey;J Am Soc Nephrol,2000

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical recommendations on diagnostics and treatment of lupus nephritis (draft project);Nephrology and Dialysis;2024-08-13

2. II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment;Advances in Rheumatology;2024-06-18

3. Do we really need cyclophosphamide for lupus nephritis?;Pediatric Nephrology;2024-04-12

4. Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment;Best Practice & Research Clinical Rheumatology;2023-12

5. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update;Annals of the Rheumatic Diseases;2023-10-12